Richmond, VA, United States of America

Vithalanand R Kulkarni

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vithalanand R Kulkarni. Retrieved from https://idiyas.com/inventor/vithalanand-r-kulkarni-2elbipc4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Vithalanand R. Kulkarni

Introduction: Vithalanand R. Kulkarni is a notable inventor based in Richmond, Virginia, with a significant contribution to the field of pharmaceuticals. His research and inventive pursuits have culminated in a patent that showcases his innovative approach to drug development.

Latest Patents: Kulkarni holds a patent for a novel process titled "Process for making 5,11-Dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e][1,4]diazepin-6-one." This invention outlines an improved methodology for synthesizing a complex compound that has potential applications in medicinal chemistry.

Career Highlights: Throughout his career, Vithalanand has made strides in pharmaceutical innovation, contributing to effective drug synthesis processes. His work at Boehringer Ingelheim International GmbH highlights his commitment to advancing the field and providing solutions that can lead to significant therapeutic advancements.

Collaborations: Vithalanand R. Kulkarni has collaborated with esteemed colleagues such as Saeed Ahmad and Robert Frederick Boswell, Jr. These partnerships have allowed him to leverage diverse expertise, enhancing his research capabilities and innovation output.

Conclusion: Vithalanand R. Kulkarni exemplifies the spirit of innovation in the pharmaceutical industry. His patent reflects not only his inventive ability but also his dedication to improving drug synthesis processes, making him a key contributor in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…